You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NBIX Sale Disclosure
Lippoldt Darin · SEC Form 4 · Filed Jul 13, 2026
Sale
Calculated transaction value
$1.8M
Lippoldt Darin Chief Legal Officer
NBIX
Transaction date
Jul 9, 2026
Public filing date
Jul 13, 2026
Filing lag
Filed 4 days later
NBIX daily price context
Close on/before transaction
$180.55
Jul 9, 2026
First close after public filing
$172.04
Jul 14, 2026
30-day return after filing
-9.04%
Through Aug 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,000 shares @ $179.6
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001504783-26-000017
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$2.61M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX | Exercise | Jul 9, 2026 | $814.9K |
| Neurocrine Biosciences Inc NBIX Current | Sale | Jul 9, 2026 | $1.8M |
| Neurocrine Biosciences Inc NBIX | Exercise | Jul 9, 2026 | $0 |